Our 6th Annual Cancer Research & Oncology Virtual Event is now available On Demand!
This free online event will bring research professionals, scientists, and clinicians from around the world to learn and discuss recent advances in cancer research. As with all LabRoots events, the Cancer Research and Oncology Event encourages a worldwide collaboration and connections between colleagues and field experts.
Cancer research has made major advancements in diagnosis, treatments, and the basic understanding of the disease itself. Each year we see progress in immunotherapy, treatments involving nanotechnology, advances in targeted and personalized therapeutics and drug development, and a decrease in mortality rates due to a strong focus on learning more about the origination of the disease.
Topic's for this years event included:
Our virtual conference allows you to participate in a global setting with no travel or cost to you. You can participate in exactly those parts which you are interested in and be back at your desk or bench in an instant. Virtual events remove time and place restrictions and ensure that everyone who wants to participate can do so. This virtual conference also offers increased reach for the global cancer community with a high degree of interaction through live-streaming video and chat sessions.
Call for Speakers — We are always looking to feature excellent research during our virtual events. If you’re working on some remarkable breakthroughs and would like to submit a speaker or panel for consideration, please submit your abstract here.
Don't forget to participate in our Leaderboard and Scavenger Hunt to win one of our Free Science T-shirts!
Continuing Education
By participating in this virtual event and watching webcast presentations, you can earn Free Continuing Education (PACE). To earn educational credits, you must view an entire presentation. Following the presentation, you must click on the educational credit link provided for that particular speaker and follow the required process. Once you have completed the process, you will receive a certificate for the educational credit.
Use #LRcancer to follow the conversation!
POSTER SUBMISSION GUIDELINES
Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Posters should be submitted as a PowerPoint file. Presentations should incorporate illustrative materials such as tables, graphs, photographs, and large-print text. This content is not peer reviewed. Submission is free.
SUBMIT YOUR ABSTRACT
Enter the following information to this Submission Form:
All submitted abstracts will be reviewed and decisions regarding acceptance will be made as abstracts are received. You will be notified within one week of receipt about acceptance. Further details and registration materials will be provided at that time. You do not have to be present in order to have a poster displayed. Only those abstracts approved by LabRoots may display posters at this event.
If accepted, you will also have the opportunity to record a 3-5 minute summary video for each poster. LabRoots will work with each individual to create these videos. Video links and email contact information will be included on each poster displayed.
Questions? Email Posters@LabRoots.com
LabRoots Policy
QIAGEN N.V., a Netherlands holding company, is the leading global provider of Sample & Assay Technologies that are used to transform biological materials into valuable molecular information. Sample technologies are used to isolate and process DNA, RNA and proteins from biological ...
See moreMiltenyi Biotec delivers solutions that advance biomedical research and cellular therapy. As the SARS-CoV-2 pandemic continues to take its toll around the world, Miltenyi Biotec stands committed to helping our customers navigate through this challenging time. With over 30 years ...
See moreIllumina is transforming human health as the global leader in sequencing and array-based technologies. Illumina's flexible and scalable sequencing systems support and enable a wide range of single-cell sequencing applications, from low-throughput deep interrogation of rare cell ...
See moreLI-COR first introduced scientific instruments for plant science research and quickly grew to provide scientists tools for such diverse disciplines as atmospheric research and the study of how proteins interact at the cellular level. LI-COR Biosciences is a global leader in the ...
See moreAt Atlas Antibodies we have a very clear mission: To provide our customers with advanced research reagents targeting all human proteins. The Human Protein Atlas (HPA) project released the first version of a complete tissue-based map of human protein expression using antibodies in ...
See moreEnvigo provides the broadest range of research models and related services to the pharmaceutical and biotechnology industries, government, academia, and other life science organizations. As the largest organization that is solely dedicated to providing research models and related ...
See moreThe IncuCyte® Real-Time Quantitative Live-Cell Analysis System, designed by Essen BioScience, Inc. is the first system to enable quantification of cell behavior over time (from hours to weeks) by automatically gathering and analyzing images around the clock. The IncuCyte® ...
See moreMitra Biotech is a global leader in advancing personalized oncology treatment and supporting more effective and efficient cancer drug development. Founded in 2010, Mitra is headquartered in Greater Boston and maintains a significant research and laboratory presence in Bengaluru ...
See moreGenTegra's mission is to protect our customer's samples from harm while in long term storage or while being transported between collection point and the laboratory or biorepository. The Active Chemical Protection™ provided by GenTegra is for weeks, months or decades. Whether ...
See moreCanon BioMedical, a wholly owned subsidiary of Canon U.S.A., Inc., is focused on empowering the biomedical research and healthcare communities by developing, manufacturing, and marketing innovative technologies and solutions. The technologies and solutions developed will help ...
See moreMillipore Sigma is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life - from biopharmaceutical therapies to treat cancer or multiple sclerosis ...
See moreInsight Pharma Reports are written by experts in consulting and industry who collaborate with us to provide a series of reports that evaluate the salient issues in pharmaceutical technology, business, and therapy markets. Insight Pharma Reports are used by leading pharmaceutical ...
See moreDr. David M. Albala graduated with a geology degree from Lafayette College in Easton, Pennsylvania. He completed his medical school training at Michigan State University and went on to complete his surgical residency at the Dartmouth-Hitchcock Medical Center. Following this, Dr ...
See moreDr. Antonio T. Baines is an Associate Professor in the Department of Biology at North Carolina Central University (NCCU) and an adjunct professor in the Department of Pharmacology in the School of Medicine at the University of North Carolina (UNC) Chapel Hill. He earned a ...
See moreDr. Blonder leads the Clinical Proteomics Group at the CRTP/FNL. FNL is a Federally Funded Research and Development Center operated by Leidos Biomedical Research, Inc., for the National Cancer Institute (NCI). In 1978, Dr. Blonder received his M.D. at the Rijeka University ...
See moreDr. Peter Blume-Jensen has extensive expertise in basic and translational cancer research, oncogenic signaling, and targeted oncology therapeutics drug discovery prior to joining Metamark as CSO in 2010. From 2001 to 2008 Peter was department head at first Serono, US and ...
See moreDr. Geaghan is Chief, Pathology at Lucile Packard Children's Hospital at Stanford, and Co-Director of Clinical Laboratories at Stanford Hospital and Clinics. She also directs the Bass Pediatric Cancer Center Laboratory at the Lucile Packard Hospital; is Director of the Point of ...
See moreDr. Rajan T. Gupta, MD, is an Assistant Professor of Radiology in the Division of Abdominal Imaging at Duke University Medical Center, as well as the Director of the Abdominal Imaging Fellowship Program and a Faculty physician in the Duke Cancer Institute. Since 2009, he has been ...
See moreFred Russell Kramer currently works at the Department of Microbiology, Biochemistry and Molecular Genetics, at the Public Health Research Institute of the New Jersey Medical School at Rutgers University. His laboratory's current current project is the design of extremely ...
See moreThe discovery of proteinaceous disease biomarkers and their clinical validation is critically important for the enablement of molecular diagnostics and ultimately, precision medicine. In spite of the importance of biomarkers, research done in the last two decades has yielded ...
See moreThe discovery of proteinaceous disease biomarkers and their clinical validation is critically important for the enablement of molecular diagnostics and ultimately, precision medicine. In spite of the importance of biomarkers, research done in the last two decades has yielded ...
See morePresident & CEO of StressMarq Biosciences Inc., a research reagent company with primary product lines in neurodegenerative diseases and cellular stress based in Victoria (BC), Canada. Successful Senior Scientific Business Executive with demonstrated expertise growing markets ...
See moreJudd W. Moul is James H. Semans, MD Professor of Surgery, Division of Urologic Surgery, and Director of the Duke Prostate Center, Duke Cancer Institute at Duke University Medical Center. Prior to joining Duke, he was Professor of Surgery at the Uniformed Services University of ...
See moreDr. Perkins joined the Melanoma Research Alliance as Chief Science Officer in 2013 where she is responsible for the development and implementation of the MRA's scientific strategy including its research award program and annual Scientific Retreat. Her interests center on ...
See moreThomas J. Polascik, M.D. is Professor in the Duke Cancer Institute, the Department of Surgery at the Duke University Medical Center, Durham, NC. Dr. Polascik trained at the Brady Urological Institute, the Johns Hopkins Hospital in Baltimore Maryland. After finishing his residency ...
See more
email support@labroots.com
Operating System | Internet Explorer | Firefox | Chrome | Safari |
---|---|---|---|---|
Vista | IE8+ | FF10+ | Chrome15+ | |
Windows 7 | IE8+ | FF10+ | Chrome15+ | Windows 8 | IE10 | FF10+ | Chrome15+ |
Mac OS X | FF10+ | Chrome15+ | Safari5.1+ |
- For viewing Webinars:
- For viewing Virtual Events
Cancer Research
Cancer Therapeutics
Cell Biology
Cancer Diagnostics
Molecular Biology
Biotechnology
Cell Culture
Immunology
Biomarkers
Biochemistry
Genetics
Oncology
Immuno-Oncology
Antibodies
Gene Expression
North America45%
Europe20%
Asia19%
Africa7%
South America6%
Oceania1%
Website Visitors76%
Email Promotions14%
Social Media Promotions5%
WAVE Newsletter Promotion3%
Website Banners1%
Other1%
Student26%
Research Scientist14%
Medical Doctor/Specialist9%
Executive9%
Educator/Faculty9%
Scientist7%
Facility/Department Manager6%
Post Doc6%
Medical Laboratory Technician4%
Clinical Laboratory Scientist2%
Lab Management2%
Consultant1%
Biologist1%
Marketing/Sales1%
Academic Institution21%
Research Institute10%
Biotech Company9%
Hospital8%
Medical School7%
Clinical Laboratory5%
Government4%
Life Science Company3%
Medical Center3%
Pharmaceutical Company3%
Non-Profit Organization2%
Consultant1%
Ambulatory Care1%
Industrial Company1%
Other6%